Cargando…

Knockdown of interferon-stimulated gene 15 affects the sensitivity of hepatocellular carcinoma cells to norcantharidin

Interferon-stimulated gene 15 (ISG15) serves a crucial role in hepatocellular carcinoma (HCC) progression. The present study explored the effect of ISG15 knockdown on the sensitivity of HCC cells to norcantharidin. The expression of ISG15 in HCC tissues and cell lines was assessed by reverse transcr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Baoxiang, Jin, Shuqiang, Bai, Bin, Li, Zhi, Ni, Caifang, Liu, Yansen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781790/ https://www.ncbi.nlm.nih.gov/pubmed/31611931 http://dx.doi.org/10.3892/etm.2019.8028

Ejemplares similares

Unique Responses of Hepatocellular Carcinoma and Cholangiocarcinoma Cell Lines toward Cantharidin and Norcantharidin
por: Ma, Qixiang, et al.
Publicado: (2018)

Interferon-stimulated Gene 15 (ISG15) is a trigger for tumorigenesis and metastasis of hepatocellular carcinoma
por: Li, Chong, et al.
Publicado: (2014)

Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma
por: Gao, Benjian, et al.
Publicado: (2021)

Norcantharidin Induces HL-60 Cells Apoptosis In Vitro
por: Jiang, You-Ming, et al.
Publicado: (2012)

Antimetastatic Effects of Norcantharidin on Hepatocellular Carcinoma by Transcriptional Inhibition of MMP-9 through Modulation of NF-kB Activity
por: Yeh, Chao-Bin, et al.
Publicado: (2012)

FAM46C is critical for the anti-proliferation and pro-apoptotic effects of norcantharidin in hepatocellular carcinoma cells
por: Zhang, Qiao-Yan, et al.
Publicado: (2017)

Correction: Antimetastatic Effects of Norcantharidin on Hepatocellular Carcinoma by Transcriptional Inhibition of MMP-9 through Modulation of NF-kB Activity
por: Yeh, Chao-Bin, et al.
Publicado: (2017)

Norcantharidin, Derivative of Cantharidin, for Cancer Stem Cells
por: Hsieh, Chen-Hsi, et al.
Publicado: (2013)

Intraperitoneal administration of thermosensitive hydrogel Co-loaded with norcantharidin nanoparticles and oxaliplatin inhibits malignant ascites of hepatocellular carcinoma
por: Xiao, Susu, et al.
Publicado: (2022)

Norcantharidin Suppresses YD-15 Cell Invasion Through Inhibition of FAK/Paxillin and F-Actin Reorganization
por: Hong, Kyoung-Ok, et al.
Publicado: (2019)

Author Correction: FAM46C is critical for the anti-proliferation and pro-apoptotic effects of norcantharidin in hepatocellular carcinoma cells
por: Zhang, Qiao-Yan, et al.
Publicado: (2017)

Metal-organic framework IRMOFs coated with a temperature-sensitive gel delivering norcantharidin to treat liver cancer
por: Li, Xiu-Yan, et al.
Publicado: (2021)

Knockdown of THOC1 reduces the proliferation of hepatocellular carcinoma and increases the sensitivity to cisplatin
por: Cai, Shijiao, et al.
Publicado: (2020)

Preparation and characterization of norcantharidin liposomes modified with stearyl glycyrrhetinate
por: Zhu, Jing, et al.
Publicado: (2018)

Strategies for Solubility and Bioavailability Enhancement and Toxicity Reduction of Norcantharidin
por: Liu, Qian, et al.
Publicado: (2022)

Norcantharidin alone or in combination with crizotinib induces autophagic cell death in hepatocellular carcinoma by repressing c-Met-mTOR signaling
por: Sun, Chao-Yue, et al.
Publicado: (2017)

Norcantharidin combined with Coix seed oil synergistically induces apoptosis and inhibits hepatocellular carcinoma growth by downregulating regulatory T cells accumulation
por: Wang, Dan, et al.
Publicado: (2017)

Review targeted drug delivery systems for norcantharidin in cancer therapy
por: Zhai, Bing-Tao, et al.
Publicado: (2022)

Norcantharidin Nanostructured Lipid Carrier (NCTD-NLC) Suppresses the Viability of Human Hepatocellular Carcinoma HepG2 Cells and Accelerates the Apoptosis
por: Yan, Zijun, et al.
Publicado: (2022)

A new core–shell-type nanoparticle loaded with paclitaxel/norcantharidin and modified with APRPG enhances anti-tumor effects in hepatocellular carcinoma
por: Xie, Ming-Hua, et al.
Publicado: (2022)

Effect of norcantharidin on the proliferation, apoptosis, and cell cycle of human mesangial cells
por: Ye, Kun, et al.
Publicado: (2017)

Facile Chemical Access to Biologically Active Norcantharidin Derivatives from Biomass
por: Galkin, Konstantin I., et al.
Publicado: (2017)

LINC02476 Promotes the Malignant Phenotype of Hepatocellular Carcinoma by Sponging miR-497 and Increasing HMGA2 Expression
por: Duan, Yuxia, et al.
Publicado: (2020)

A simple route to a novel acid-sensitive 20(S)-O-linked camptothecin norcantharidin acid ester derivative
por: Zhao, Changkuo, et al.
Publicado: (2018)

LncRNA Lnc712 Promotes Tumorigenesis in Hepatocellular Carcinoma by Targeting miR-142-3p/Bach-1 Axis
por: Cui, Dan, et al.
Publicado: (2020)

Norcantharidin ameliorates the development of murine lupus via inhibiting the generation of IL-17 producing cells
por: Du, Li-jun, et al.
Publicado: (2021)

Nucleostemin Knockdown Sensitizes Hepatocellular Carcinoma Cells to Ultraviolet and Serum Starvation-Induced Apoptosis
por: Yuan, Fuwen, et al.
Publicado: (2015)

Folate receptor-targeted liposomes loaded with a diacid metabolite of norcantharidin enhance antitumor potency for H22 hepatocellular carcinoma both in vitro and in vivo
por: Liu, Min-Chen, et al.
Publicado: (2016)

Novel norcantharidin-loaded liver targeting chitosan nanoparticles to enhance intestinal absorption
por: Bei, Yong-yan, et al.
Publicado: (2012)

Norcantharidin Inhibits Renal Interstitial Fibrosis by Blocking the Tubular Epithelial-Mesenchymal Transition
por: Li, Ying, et al.
Publicado: (2013)

Strontium/Chitosan/Hydroxyapatite/Norcantharidin Composite That Inhibits Osteosarcoma and Promotes Osteogenesis In Vitro
por: Huang, Zhipeng, et al.
Publicado: (2020)

Norcantharidin down-regulates iron contents in the liver and spleen of lipopolysaccharide-treated mice
por: Zheng, Jie, et al.
Publicado: (2022)

The prognostic significance of interferon-stimulated gene 15 (ISG15) in invasive breast cancer
por: Kariri, Yousif A., et al.
Publicado: (2020)

Hsa_circ_0011385 knockdown represses cell proliferation in hepatocellular carcinoma
por: Ni, Chuangye, et al.
Publicado: (2021)

Type 1 Interferons Inhibit Myotube Formation Independently of Upregulation of Interferon-Stimulated Gene 15
por: Franzi, Sara, et al.
Publicado: (2013)

Correction: Norcantharidin Inhibits Renal Interstitial Fibrosis by Blocking the Tubular Epithelial-Mesenchymal Transition
por: Li, Ying, et al.
Publicado: (2013)

Synthesis and Biological Evaluation of Norcantharidin Derivatives Possessing an Aromatic Amine Moiety as Antifungal Agents
por: Wang, Yang, et al.
Publicado: (2015)

Modified quantitative and volumetric response evaluation criteria for patients with hepatocellular carcinoma after transarterial chemoembolization
por: Xu, Jiachen, et al.
Publicado: (2023)

Norcantharidin-Encapsulated C60-Modified Nanomicelles: A Potential Approach to Mitigate Cytotoxicity in Renal Cells and Simultaneously Enhance Anti-Tumor Activity in Hepatocellular Carcinoma Cells
por: Ding, Zhongpeng, et al.
Publicado: (2023)

Knockdown of TANK-Binding Kinase 1 Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular-Targeted Drugs
por: Du, Fengxia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h5kh1bhatuopi5fs5jq2sbc78o